date:Feb 25, 2019
rts of negative patient side effects or other concerns suggest a problem with a drug, the FDA investigates and, when appropriate, may require changes in how a medicine (both brand-name and generic versions) is used or manufactured.
FACT: We closely analyze reams of data to ensure the quality and safety of manufacturing throughout a products lifecycle
The FDA monitors many sources of data to ensure the safety and quality of generic manufacturing. One of the fundamental elements of overseeing th